恶液质如何治疗？日本推出首款恶液质治疗药Adlumiz

Cachexia is also called cachexia. Cachexia is mostly caused by cancer and other serious chronic diseases, among which cachexia associated with tumors is the most common. It is called cancer cachexia (CC). Several clinical trials have been conducted to explore the drug intervention treatment of tumor cachexia. However, there are not many clinical trials with positive results, and (anamorelin) is one of the more outstanding results. How is cachexia treated?

Adlumiz (anamorelin) is a new oral drug. Adlumiz (anamorelin) is the first drug to treat cancer cachexia. Adlumiz (anamorelin) is used to treat cancer cachexia (CC) in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, colorectal cancer and other malignant tumors.

Adlumiz (anamorelin) acts on the ghrelin receptor GHS-R1a (growth hormone release-promoting factor receptor type 1a). Adlumiz (anamorelin) promotes growth hormone (GH) secretion by activating GHS-R1a and increasing appetite, which leads to weight gain.

Adlumiz (anamorelin) is the first drug to treat cancer cachexia. Clinical data shows that Adlumiz (anamorelin) can increase body weight, muscle mass, and appetite in patients with cancer cachexia. The launch of Adlumiz (anamorelin) will provide a new treatment option for patients with cancer cachexia and help improve the quality of life of these patients.

Adlumiz (anamorelin) usage and dosage

The recommended dose for adult treatment with Adlumiz (anamorelin) is: 100 mg orally once daily on an empty stomach. Patients should strictly follow the doctor's instructions during treatment with Adlumiz (anamorelin) and should not increase or decrease the dosage of Adlumiz (anamorelin) without authorization to avoid adverse reactions caused by increased or reduced dosage.

The above is the introduction about Adlumiz (anamorelin). If patients want to know more drug information about Adlumiz (anamorelin), they can consult the medical companion travel service.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended hot articles